United States:
Podcast: CBD, THC, FDA – What You Need To Know About Cannabis And Its Regulation
25 July 2019
Akin Gump Strauss Hauer & Feld LLP
To print this article, all you need is to be registered or login on Mondaq.com.
Subscribe to OnAir with Akin Gump via iTunes, SoundCloud, YouTube, Spotify and Google Play.
In this episode, Akin Gump health care and life sciences partner
Howard Sklamberg discusses the history and status of cannabis
regulation and enforcement in the U.S., particularly of
cannabidiol, or CBD.
Among the topics covered:
- THC vs. CBD, hemp vs. marijuana
- CBD and the Controlled Substances
Act
- CBD: supplement, food additive or
drug?
- FDA regulation of CBD.
Download PDF
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
Healthcare Policy Developments To Watch In 2024
Crowell & Moring LLP
The ever-changing healthcare policy landscape will witness at the federal level regulatory changes driven by the need to transform healthcare delivery, quality and innovation.
The FDA And The Future Of AI Oversight
Manatt, Phelps & Phillips LLP
In January 2024, the U.S. Government Accountability Office (GAO) issued a report highlighting current obstacles to the U.S. Food and Drug Administration's (FDA) timely and effective regulation...